Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $263.07 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $125.00 | 1 | $0 (2022) |
| GlaxoSmithKline, LLC. | $42.46 | 2 | $0 (2021) |
| Lilly USA, LLC | $39.54 | 2 | $0 (2021) |
| PFIZER INC. | $34.19 | 2 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $21.88 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $125.00 | 1 | ABBVIE INC. ($125.00) |
| 2021 | $138.07 | 7 | GlaxoSmithKline, LLC. ($42.46) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/23/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2021 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BOOSTRIX | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: VACCINES | ||||||
| 07/08/2021 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: VACCINES | ||||||
| 04/27/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/27/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/17/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Diabetes | ||||||
| 02/09/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 02/03/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Diabetes | ||||||
About Robin Desrosiers, NP
Robin Desrosiers, NP is a Nurse Practitioner healthcare provider based in Walden, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1295866523.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robin Desrosiers, NP has received a total of $263.07 in payments from pharmaceutical and medical device companies, with $125.00 received in 2022. These payments were reported across 8 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($263.07).
Practice Information
- Specialty Nurse Practitioner
- Location Walden, NY
- Active Since 03/08/2007
- Last Updated 07/08/2007
- Taxonomy Code 363L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1295866523
Products in Payments
- UBRELVY (Drug) $125.00
- SHINGRIX (Biological) $42.46
- TRULICITY (Drug) $39.54
- ELIQUIS (Drug) $34.19
- SOLIQUA 100/33 (Biological) $21.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.